Skip to main content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2006 | OriginalPaper | Hoofdstuk

Hoe denkt men tegenwoordig over de therapie met digoxine?

Auteur : M.M. Tjoeng

Gepubliceerd in: Vademecum permanente nascholing huisartsen

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Sinds William Withering’s monografie uit 1785 over het gebruik en de toxiciteit van de bladeren van het vingerhoedskruid, zijn de digitalisglycosiden toegepast voor de behandeling van waterzucht, tegenwoordig congestief hartfalen geheten. In de therapie van het congestief hartfalen is nu veel meer mogelijk. Het is dan ook zaak een goed oordeel te hebben over de bijdrage die digoxine kan leveren in het farmacotherapeutisch arsenaal. Eerst komt de plaats van digoxine bij hartfalen met een systolische disfunctie aan de orde. Vervolgens wordt ingegaan op het gebruik van digoxine bij atriumfibrilleren.
Literatuur
go back to reference Smith TW. Digitalis: Mechanisms of action and clinical use. N Engl J Med 1988; 318: 358. Smith TW. Digitalis: Mechanisms of action and clinical use. N Engl J Med 1988; 318: 358.
go back to reference Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors (Radiance trial). N Engl J Med 1993; 17: 743. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors (Radiance trial). N Engl J Med 1993; 17: 743.
go back to reference Uretsky BF, Young JB, Shadidi FE, et al. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. J Am Coll Cardiol 1993; 22: 955. Uretsky BF, Young JB, Shadidi FE, et al. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. J Am Coll Cardiol 1993; 22: 955.
go back to reference The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525.
go back to reference Adams KF, Georghiade M, Uretsky BF, et al. Clinical predictors of worsening of heart failure during withdrawal from digoxin therapy. Am Heart J 1998; 135: 389. Adams KF, Georghiade M, Uretsky BF, et al. Clinical predictors of worsening of heart failure during withdrawal from digoxin therapy. Am Heart J 1998; 135: 389.
go back to reference Ward RE, Georghiade M, Young JB, Uretsky B. Economic outcomes of withdrawal of diogoxin therapy in adult patients with stable congestive heart failure. J Am Coll Cardiol 2001; 38: 806. Ward RE, Georghiade M, Young JB, Uretsky B. Economic outcomes of withdrawal of diogoxin therapy in adult patients with stable congestive heart failure. J Am Coll Cardiol 2001; 38: 806.
go back to reference Rich MW, McSherry F, Williford WO, Yusuf S. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. J Am Coll Cardiol 2001; 38: 806. Rich MW, McSherry F, Williford WO, Yusuf S. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. J Am Coll Cardiol 2001; 38: 806.
go back to reference Rathore SS, Curtis JP, Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003; 289: 871. Rathore SS, Curtis JP, Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003; 289: 871.
go back to reference Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002; 347: 1403. Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002; 347: 1403.
go back to reference Adams KF, Georghiade M, Uretsky BF, et al. Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol 2002; 39: 946. Adams KF, Georghiade M, Uretsky BF, et al. Clinical benefits of low serum digoxin concentrations in heart failure. J Am Coll Cardiol 2002; 39: 946.
go back to reference Malkin CJ, Channer KS. Life-saving or life-prolonging? Interpreting data and survival curves for patients with congestive heart failure. Eur J Heart Failure 2005; 7: 143. Malkin CJ, Channer KS. Life-saving or life-prolonging? Interpreting data and survival curves for patients with congestive heart failure. Eur J Heart Failure 2005; 7: 143.
go back to reference The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 2002; 4: 11-22. The task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 2002; 4: 11-22.
go back to reference Falk RH, Leavitt JI. Digoxin for atrial fibrillation: A drug whose time has gone? Ann Intern Med 1991; 114: 993. Falk RH, Leavitt JI. Digoxin for atrial fibrillation: A drug whose time has gone? Ann Intern Med 1991; 114: 993.
go back to reference Sarter BH, Marchlinsky FE. Redefining the role of digoxin in the treatment of atrial fibrillation. Am J Cardiol 1992; 69: 71G. Sarter BH, Marchlinsky FE. Redefining the role of digoxin in the treatment of atrial fibrillation. Am J Cardiol 1992; 69: 71G.
go back to reference Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. J Am Coll Cardiol 2001; 38: 1231. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. J Am Coll Cardiol 2001; 38: 1231.
Metagegevens
Titel
Hoe denkt men tegenwoordig over de therapie met digoxine?
Auteur
M.M. Tjoeng
Copyright
2006
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8808-0_18